<DOC>
	<DOCNO>NCT00254969</DOCNO>
	<brief_summary>The present clinical study assess immunogenicity reactogenicity Aventis Pasteur 's DTacP-IPV// PRP~T combine vaccine ( Pentavac™ Pentaxim™ ) three-dose primary vaccination 6 , 10 14 week age follow booster dose second year life order meet requirement application use product Expanded Program Immunization ( EPI ) South Africa .</brief_summary>
	<brief_title>Immunogenicity Safety Pentaxim South African Infants</brief_title>
	<detailed_description />
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Poliomyelitis</mesh_term>
	<mesh_term>Haemophilus Infections</mesh_term>
	<criteria>Aged &lt; 24 hour day inclusion At visit 01 ( screen ) Illness stage could interfere trial conduct completion . Any vaccination precede trial participation ( except Bacille CalmetteGuerin [ BCG ] ) Acute illness day screen . At visit 01 visit 02 ( screen first study vaccination ) . Planned participation another clinical trial present trial period Blood bloodderived product receive since birth . Mother known seropositive HIV hepatitis B . Known thrombocytopenia bleed disorder contraindicate intramuscular vaccination History of/current seizures visit 02 ( first study vaccination ) Participation another clinical trial precede first trial vaccination Congenital acquire immunodeficiency ; immunosuppressive therapy longterm systemic corticosteroid therapy . Systemic hypersensitivity vaccine component history lifethreatening reaction trial vaccine vaccine contain substance Chronic illness stage could interfere trial conduct completion . Any vaccination precede first trial vaccination ( except BCG ) History diphtheria , tetanus , pertussis , poliomyelitis , Haemophilus influenzae type b hepatitis B infection ( confirm either clinically , serologically microbiologically ) . Previous vaccination diphtheria , tetanus , pertussis , poliomyelitis , Haemophilus influenzae type b hepatitis B infection trial vaccine another vaccine . Febrile illness ( rectal temperature ≥ 38.0°C axillary temperature ≥ 37.4°C ) acute illness day first vaccination</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Diphteria</keyword>
	<keyword>tetanus</keyword>
	<keyword>haemophilus influenzae type b</keyword>
	<keyword>poliomyelitis</keyword>
	<keyword>pertussis</keyword>
</DOC>